368 related articles for article (PubMed ID: 36232872)
1. Identification of Diosmin and Flavin Adenine Dinucleotide as Repurposing Treatments for Monkeypox Virus: A Computational Study.
Lam TP; Tran VH; Mai TT; Lai NV; Dang BN; Le MT; Tran TD; Trinh DT; Thai KM
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232872
[TBL] [Abstract][Full Text] [Related]
2.
Podduturi S; Vemula D; Singothu S; Bhandari V
J Biomol Struct Dyn; 2023 Aug; ():1-14. PubMed ID: 37555596
[TBL] [Abstract][Full Text] [Related]
3. Unexpectedly higher levels of anti-orthopoxvirus neutralizing antibodies are observed among gay men than general adult population.
Feng Y; Zhang Y; Liu S; Guo M; Huang H; Guo C; Wang W; Zhang W; Tang H; Wan Y
BMC Med; 2023 May; 21(1):183. PubMed ID: 37189197
[TBL] [Abstract][Full Text] [Related]
4. Contriving multi-epitope vaccine ensemble for monkeypox disease using an immunoinformatics approach.
Aziz S; Almajhdi FN; Waqas M; Ullah I; Salim MA; Khan NA; Ali A
Front Immunol; 2022; 13():1004804. PubMed ID: 36311762
[TBL] [Abstract][Full Text] [Related]
5. Monkeypox virus: a re-emergent threat to humans.
Gong Q; Wang C; Chuai X; Chiu S
Virol Sin; 2022 Aug; 37(4):477-482. PubMed ID: 35820590
[TBL] [Abstract][Full Text] [Related]
6. Monkeypox, a Literature Review: What Is New and Where Does This concerning Virus Come From?
Tiecco G; Degli Antoni M; Storti S; Tomasoni LR; Castelli F; Quiros-Roldan E
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146705
[TBL] [Abstract][Full Text] [Related]
7. Screening of potential inhibitors against structural proteins from Monkeypox and related viruses of
Kaur M; Sharma A; Kaur H; Singh M; Devi B; Naresh Raj AR; Sood V; Pandey A; Gartia J; Kumar R; Suresh Babu AR; Singh G; Barnwal RP
J Biomol Struct Dyn; 2023 Sep; ():1-16. PubMed ID: 37776002
[TBL] [Abstract][Full Text] [Related]
8. Multi-epitope chimeric vaccine design against emerging Monkeypox virus
Aiman S; Alhamhoom Y; Ali F; Rahman N; Rastrelli L; Khan A; Farooq QUA; Ahmed A; Khan A; Li C
Front Immunol; 2022; 13():985450. PubMed ID: 36091024
[TBL] [Abstract][Full Text] [Related]
9. Strategy of developing nucleic acid-based universal monkeypox vaccine candidates.
Papukashvili D; Rcheulishvili N; Liu C; Wang X; He Y; Wang PG
Front Immunol; 2022; 13():1050309. PubMed ID: 36389680
[TBL] [Abstract][Full Text] [Related]
10. Current Status of Vaccine Development for Monkeypox Virus.
Rastogi A; Kumar M
Adv Exp Med Biol; 2024; 1451():289-300. PubMed ID: 38801585
[TBL] [Abstract][Full Text] [Related]
11. Monkeypox virus: The changing facets of a zoonotic pathogen.
Forni D; Cagliani R; Molteni C; Clerici M; Sironi M
Infect Genet Evol; 2022 Nov; 105():105372. PubMed ID: 36202208
[TBL] [Abstract][Full Text] [Related]
12. In silico identification of potential inhibitors of vital monkeypox virus proteins from FDA approved drugs.
Sahoo AK; Augusthian PD; Muralitharan I; Vivek-Ananth RP; Kumar K; Kumar G; Ranganathan G; Samal A
Mol Divers; 2023 Oct; 27(5):2169-2184. PubMed ID: 36331784
[TBL] [Abstract][Full Text] [Related]
13. Monkeypox Virus Host Factor Screen Using Haploid Cells Identifies Essential Role of GARP Complex in Extracellular Virus Formation.
Realegeno S; Puschnik AS; Kumar A; Goldsmith C; Burgado J; Sambhara S; Olson VA; Carroll D; Damon I; Hirata T; Kinoshita T; Carette JE; Satheshkumar PS
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331092
[No Abstract] [Full Text] [Related]
14. Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo.
Priyamvada L; Carson WC; Ortega E; Navarra T; Tran S; Smith TG; Pukuta E; Muyamuna E; Kabamba J; Nguete BU; Likafi T; Kokola G; Lushima RS; Tamfum JM; Okitolonda EW; Kaba DK; Monroe BP; McCollum AM; Petersen BW; Satheshkumar PS; Townsend MB
Vaccine; 2022 Nov; 40(50):7321-7327. PubMed ID: 36344361
[TBL] [Abstract][Full Text] [Related]
15. Identification of
Chiem K; Nogales A; Lorenzo M; Morales Vasquez D; Xiang Y; Gupta YK; Blasco R; de la Torre JC; MartÃnez-Sobrido L
Microbiol Spectr; 2023 Aug; 11(4):e0474522. PubMed ID: 37278625
[TBL] [Abstract][Full Text] [Related]
16. AI-driven drug repurposing and binding pose meta dynamics identifies novel targets for monkeypox virus.
Patel CN; Mall R; Bensmail H
J Infect Public Health; 2023 May; 16(5):799-807. PubMed ID: 36966703
[TBL] [Abstract][Full Text] [Related]
17. Exploration of Microbially Derived Natural Compounds against Monkeypox Virus as Viral Core Cysteine Proteinase Inhibitors.
Dubey A; Alawi MM; Alandijany TA; Alsaady IM; Altwaim SA; Sahoo AK; Dwivedi VD; Azhar EI
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680291
[TBL] [Abstract][Full Text] [Related]
18. Development of multi-epitope vaccines against the monkeypox virus based on envelope proteins using immunoinformatics approaches.
Tan C; Zhu F; Pan P; Wu A; Li C
Front Immunol; 2023; 14():1112816. PubMed ID: 36993967
[TBL] [Abstract][Full Text] [Related]
19. Designing, characterization, and immune stimulation of a novel multi-epitopic peptide-based potential vaccine candidate against monkeypox virus through screening its whole genome encoded proteins: An immunoinformatics approach.
Bhattacharya M; Chatterjee S; Nag S; Dhama K; Chakraborty C
Travel Med Infect Dis; 2022; 50():102481. PubMed ID: 36265732
[TBL] [Abstract][Full Text] [Related]
20. Identifying potential monkeypox virus inhibitors: an
Ashley CN; Broni E; Wood CM; Okuneye T; Ojukwu MT; Dong Q; Gallagher C; Miller WA
Front Cell Infect Microbiol; 2024; 14():1351737. PubMed ID: 38500508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
